Early Access — free while we kick the tires
EdgarHawk

Modi Rajeev A.

SEE REMARKS

Officer

Latest: Officer buying · May 2026

2 filings analyzed · 1 company · Latest 2026-05-19

Companies

Company Buys Sells Direction
Elanco Animal Health Inc ELAN 2 0 Net buying

Activity

May 2026
medium
Buy
4,911 shares
$99,939
Significance 5/10

Modi Rajeev A. bought 4,911 shares of ELAN at $20.35 on 2026-05-15; stock now down -28.6% from 52-week high.

Modi Rajeev A. purchased 4,911 shares at $20.35 on 2026-05-15, increasing holdings by 3.2% to 160,812 shares post-transaction. The transaction occurs as ELAN trades at $19.80, down -16.4% over 30 days and down -28.6% from its 52-week high of $27.72. While Modi's prior buy at this ticker (2025-12-11) produced positive 90-day returns and was well-timed, the current price action presents a contrasting backdrop. The company generated $1,371,000,000 in latest quarterly revenue with a market cap of $9,889,101,743.40, though it reported negative full-year net income despite posting $57,000,000 in quarterly net income. The timing of this purchase against the stock's recent downward trajectory and the company's broader profitability challenges merit investor attention.

December 2025
high
Buy
4,500 shares
$95,985
Significance 6/10

Modi Rajeev A. purchases 4,500 shares of ELAN at $21.33; cluster pattern with 3 other insiders buying within 14 days

Modi Rajeev A. purchased 4,500 shares at $21.33, bringing holdings to 123,082 shares—a +3.8% increase versus pre-transaction holdings. The transaction occurs alongside a cluster pattern: 3 other insiders also bought within the past 14 days, indicating coordinated insider accumulation at the same price level. The stock trades at $21.70 currently, only −7.4% from its 52-week high of $23.43, though the company reports a negative net income of $−34.0M against revenue of $1.1B, with an elevated P/E of 310.00 reflecting subdued earnings. The 90-day price momentum of +16.5% and 30-day gain of +2.9% show recent strength despite fundamental headwinds. Synchronized insider purchases during a recovery phase warrant investor attention to whether management perceives improved near-term prospects.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access